EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetic and Pharmacodynamic Properties of Metronidazole in Pediatric Patients With Acute Appendicitis: A Prospective Study

Jason Child, Xinhui Chen, Rakesh D Mistry, Stig Somme, Christine MacBrayne, Peter L Anderson, Ronald N Jones, Sarah K Parker

Journal of the Pediatric Infectious Diseases Society · 25.09.2019 · 8 (4) · 297-302

DOI: 10.1093/jpids/piy040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 16.05.2018. Verfasst von Jason Child und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Children's Hospital Colorado, Aurora. Hauptthemen laut MEDLINE: Acute Disease. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metronidazole is traditionally dosed every 6–8 hours even though in adults it has a long half-life, concentration-dependent killing, and 3-hour postantibiotic effect. Based on this logic, some pediatric hospitals adopted once-daily dosing for appendicitis, despite limited pharmacokinetics-pharmacodynamics (PK/PD) in children. We studied pediatric patients with appendicitis given metronidazole once daily to determine whether this dosing would meet target area under the curve (AUC)/minimum inhibitory concentration (MIC) ratio of ≥70 for Bacteroides fragilis.

Methods

One hundred pediatric patients aged 4–17 years had an average of 3 blood draws per patient during the first 24 hours after a 30 mg/kg per dose of intravenous metronidazole. Concentrations of drug were determined using validated liquid chromatography and tandem mass spectrometry. A NONMEM model was constructed for determining PK, followed by Monte Carlo simulations to generate a population of plasma concentration-time AUC of metronidazole and hydroxy-metronidazole.

Results

Simulated AUC values met target attainment (AUC/MIC ratio of ≥70 to B fragilis MICs) for 96%–100% of all patients for an MIC of 2 mcg/mL. For MICs of 4 and 8 mcg/mL, target attainment ranged from 61% to 97% and 9% to 71%, respectively. Areas under the curve were similar to that of adults receiving 1000 mg and 1500 mg q24, or 500 mg q8 hours.

Conclusions

Metronidazole, 30 mg/kg per dose, once daily achieved AUC target attainment for B fragilis with an MIC of 2 mcg/mL or less in pediatric appendicitis patients. Based on this and studies in adults, there does not seem to be any PK/PD advantage of more frequent dosing in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute DiseaseAdolescentAppendicitisArea Under CurveBacteroides fragilisChildChild, PreschoolFemaleHumansMaleMetronidazoleMicrobial Sensitivity TestsMonte Carlo MethodProspective Studies

Stichwörter der Autor:innen

appendicitisarea under the concentration time curvemetronidazoleminimum inhibitory concentrationpharmacokinetic

Substanzen

Metronidazole

Autor:innen und Institutionen

  • Department of Pharmacy, Children's Hospital Colorado, Aurora.
  • University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora.
  • Section of Emergency Medicine, Department of Pediatrics, Children's Hospital Colorado, Aurora.
  • Division of General, Thoracic, and Fetal Pediatric Surgery, Department of Pediatrics, Children's Hospital Colorado, Aurora.
  • JMI Laboratories, North Liberty, Iowa.
  • Section of Infectious Diseases, Department of Pediatrics, Children's Hospital Colorado, Aurora.

Zitieren

APA

Child, J., Chen, X., Mistry, R. D., Somme, S., MacBrayne, C., Anderson, P. L., Jones, R. N., & Parker, S. K. (2019). Pharmacokinetic and Pharmacodynamic Properties of Metronidazole in Pediatric Patients With Acute Appendicitis: A Prospective Study. Journal of the Pediatric Infectious Diseases Society, 8(4), 297-302. https://doi.org/10.1093/jpids/piy040

Vancouver

Child J, Chen X, Mistry RD, Somme S, MacBrayne C, Anderson PL, et al. Pharmacokinetic and Pharmacodynamic Properties of Metronidazole in Pediatric Patients With Acute Appendicitis: A Prospective Study. Journal of the Pediatric Infectious Diseases Society. 2019;8(4):297-302. doi:10.1093/jpids/piy040

BibTeX
@article{Child2019,
  author = {Child, Jason and Chen, Xinhui and Mistry, Rakesh D and Somme, Stig and MacBrayne, Christine and Anderson, Peter L and Jones, Ronald N and Parker, Sarah K},
  title = {Pharmacokinetic and Pharmacodynamic Properties of Metronidazole in Pediatric Patients With Acute Appendicitis: A Prospective Study},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2019},
  volume = {8},
  number = {4},
  pages = {297--302},
  doi = {10.1093/jpids/piy040}
}
Kostenlos starten →